Prostaglandin analog for treating osteoporosis
US5409911A · kind A · utility
32Cited by
10References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 1992 |
| Grant date | Apr 25, 1995 |
| Priority date | — |
| Expiry date | Sep 11, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/3873
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a prostaglandin-bisphosphonate compound of the formula: ##STR1## and its pharmaceutically acceptable salts. The claimed compounds are effective as delivery agents of prostaglandins to treat osteoporosis and related bone diseases. The claimed compounds also simultaneously deliver a bisphosphonate which inhibits bone resorption and delivers prostaglandins which increase bone formation in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.